Drugs / PA101B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02696499 | Feb → Aug 2016 | — | Patara Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PA101B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02696499 ↗ |
| Route | Inhaled | “administered via inhalation” NCT02696499 ↗ |